Annual Lung SPORE Workshop (Abstract Submission)

Filter submissions
76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Mon, 03/11/2024 - 13:03 Jensen Abascal jensenabascal@g.ucla.edu (310) 266-8937 Session 3: Immuno-oncology In situ vaccination with Flt3l gene modified CD103+ type 1 conventional dendritic cells synergizes with anti-PD-1 checkpoint blockade in murine models of non-small cell lung cancer Jensen Abascal Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Raymond
    Last Name: Lim
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA.
  • First Name: Ramin
    Last Name: Salehi Rad
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, California
  • First Name: Zhe
    Last Name: Jing
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Michael
    Last Name: Oh
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA;
  • First Name: William
    Last Name: Crosson
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA.
  • First Name: Bitta
    Last Name: Kahangi
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Edgar
    Last Name: Perez Reyes
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Camelia
    Last Name: Dumitras
    Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Diana
    Last Name: Reyimjan
    Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Linh
    Last Name: Tran
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Manash
    Last Name: Paul
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Kostyantyn
    Last Name: Krysan
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Bin
    Last Name: Liu
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Steven
    Last Name: Dubinett
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Pathology and Laboratory Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, Ca
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:12 Esra Akbay esra.akbay@utsouthwestern.edu 2146484159 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models Esra Akbay UT Southwestern Medical Center Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:59 Mustafa Al-Dulaimi mustafa_al-dulaimi@dfci.harvard.edu 12087180181 Session 6: Cancer Biology CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC) Mustafa Al-Dulaimi DFCI
  • First Name: Antja-Voy
    Last Name: Hartley
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Matthew
    Last Name: Booker
    Affiliation: DFCI
  • First Name: Nathanael
    Last Name: Gray
    Affiliation: Stanford Cancer Institute
  • First Name: Michael
    Last Name: Tolsturokov
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Janne
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:09 Arnaud Augert arnaud.augert@yale.edu Session 4: Small Cell Lung Cancer The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC Arnaud Augert Yale University Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:40 Kelly Becht kelly.becht@yale.edu (603) 401-2345 Session 2: Health Disparities in Lung Cancer Disparities in Stereotactic Radiosurgery Receipt in Patients with Brain Metastases from Non-Small Cell Lung Cancer Kelly Becht Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Meghan
    Last Name: Lindsay
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: Pamela
    Last Name: Soulos
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: James
    Last Name: Hansen
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Charu
    Last Name: Singh
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Yi
    Last Name: An
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sanjay
    Last Name: Aneja
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Department of Medicine, Section of Medical Oncology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Henry
    Last Name: Park
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:25 Alice Berger ahberger@fredhutch.org 2066676281 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Systematic discovery of osimertinib resistance variants using CRISPR prime editing Alice Berger Fred Hutch Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 06:48 Elliott Brea elliott_brea@dfci.harvard.edu 8479221042 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings Elliott Brea DFCI
  • First Name: Eric
    Last Name: Smith
    Affiliation: DFCI
  • First Name: David
    Last Name: Barbie
    Affiliation: DFCI
  • First Name: Sachiv
    Last Name: Chakravarti
    Affiliation: DFCI
  • First Name: Alexis
    Last Name: Mottram
    Affiliation: DFCI
  • First Name: Prafulla
    Last Name: Gokhale
    Affiliation: DFCI
  • First Name: Ken
    Last Name: Ng
    Affiliation: DFCI
  • First Name: Cloud
    Last Name: Paweletz
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Elena
    Last Name: Ivanova
    Affiliation: DFCI
  • First Name: Ha
    Last Name: Vo
    Affiliation: DFCI
  • First Name: Tran
    Last Name: Thai
    Affiliation: DFCI
  • First Name: Timothy
    Last Name: Haggerty
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 23:49 Ling Cai ling.cai.30@gmail.com 2146975362 Session 6: Cancer Biology A Lung Cancer Mouse Model Database Ling Cai Quantitative Biomedical Research Center, School of Public Health, University of Texas Southwestern Medical Center Abstract_Submission.pdf
Cai_UTSW_6.docx15.39 KB
No Approved to be a Poster Presenter
Mon, 03/11/2024 - 08:39 Jordan Cardenas jordan.cardenas@yale.edu 3039196514 Session 3: Immuno-oncology The combination of modified IL-18 with anti-PD1 elicits a CD4+ T cell-mediated antitumor response in MHC Class I-deficient models of non-small cell lung cancer Jordan Cardenas Yale
  • First Name: Camila
    Last Name: Robles-Oteiza
    Affiliation: Yale
  • First Name: Ting
    Last Name: Zhou
    Affiliation: Yale
  • First Name: John
    Last Name: Huck
    Affiliation: Yale
  • First Name: Paula
    Last Name: Kavathas
    Affiliation: Yale
  • First Name: Aaron
    Last Name: Ring
    Affiliation: Fred Hutch
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Fri, 03/08/2024 - 13:42 Sampada Chande sampada.chande@yale.edu 6097722949 Session 6: Cancer Biology Characterization of tumor-neuron communication in lung adenocarcinoma brain metastasis Sampada Chande Department of Pathology, Yale University School of Medicine
  • First Name: Atsushi
    Last Name: Yamasaki
    Affiliation: Daiichi Sankyo Co., Ltd., Tokyo, Japan
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Department of Pathology, Yale University School of Medicine
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:33 Darin Dolezal darin.dolezal@yale.edu 203-584-4276 Session 6: Cancer Biology Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer Darin Dolezal Yale School of Medicine - Department of Pathology
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal Estapé
    Affiliation: Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale School of Medicine
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
 Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:46 Austin Draycott austin.draycott@yale.edu 3475969754 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer Austin Draycott Yale University
  • First Name: Matthew
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Diana
    Last Name: Martínez Saucedo
    Affiliation: Yale University
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Yale University
  • First Name: Wendy
    Last Name: Gilbert
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/31/2024 - 18:56 Loretta Erhunmwunsee lorettae@coh.org 6262187287 Session 2: Health Disparities in Lung Cancer Reducing Racial Residential Segregation Lowers the Risk of Lung Cancer in African Americans Yi Xiao COH
  • First Name: Xiaoke
    Last Name: Zou
    Affiliation: COH
  • First Name: Calvin
    Last Name: Tribby
    Affiliation: COH
  • First Name: Peter
    Last Name: Vien
    Affiliation: COH
  • First Name: Christina
    Last Name: Chang
    Affiliation: COH
  • First Name: Richard
    Last Name: Curley
    Affiliation: COH
  • First Name: Olutola
    Last Name: Akande
    Affiliation: COH
  • First Name: Melinda
    Last Name: Aldrich
    Affiliation: VUMC
  • First Name: Sophia
    Last Name: Wang
    Affiliation: COH
  • First Name: RIck
    Last Name: Kittles
    Affiliation: MSM
  • First Name: Kimlin
    Last Name: Ashing
    Affiliation: COH
  • First Name: Lennie
    Last Name: Wong
    Affiliation: COH
  • First Name: Marta
    Last Name: Jankowska
    Affiliation: COH
  • First Name: Tarik
    Last Name: Benmarhnia
    Affiliation: Scripps Institution of Oceanography
  • First Name: Loretta
    Last Name: Erhunmwunsee
    Affiliation: COH
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 09:40 Francisco Exposito francisco.exposito@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer Francisco Exposito Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA
  • First Name: Emily
    Last Name: Shuldiner
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Steven
    Last Name: Lopez
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Minwei
    Last Name: Wang
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Mariana
    Last Name: Do Carmo
    Affiliation: Department of Pathology, Yale School of Medicine, New Haven, CT, USA
  • First Name: Laura
    Last Name: Andrejka
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Giorgia
    Last Name: Foggetti
    Affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • First Name: Christopher
    Last Name: W. Murray
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Dimitri
    Last Name: Petrov
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Monte
    Last Name: Winslow
    Affiliation: Division of Oncology, Department of Medicine / Stanford Cancer Institute / Department of Pathology, Stanford University School of Medicine, Stanford, California
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale School of Medicine / Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:56 Florian Fintelmann fintelmann@mgh.harvard.edu 6178490063 Session 5: Early Detection and Screening Significance of image acquisition parameters for Sybil’s ability to predict future lung cancer risk on low-dose chest computed tomography Judit Simon MGH
  • First Name: Peter
    Last Name: Mikhael
    Affiliation: MIT
  • First Name: Alexander
    Last Name: Graur
    Affiliation: MGH
  • First Name: Regina
    Last Name: Barzilay
    Affiliation: MIT
  • First Name: Lecia
    Last Name: Sequist
    Affiliation: MGH
  • First Name: Florian
    Last Name: Fintelmann
    Affiliation: MGH
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 15:01 Janet Freeman-Daily janet.f-d@comcast.net 253-606-2173 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Partnering with Patient Research Advocates Janet Freeman-Daily Fred Hutch SPORE (patient advocate)
  • First Name: Elda
    Last Name: Railey
    Affiliation: Research Advocacy Network
 Abstract_Submission.pdf No Approved to be a Speaker
Fri, 03/08/2024 - 19:37 Boning Gao boning.gao@utsouthwestern.edu 2146484915 Session 6: Cancer Biology New human cell line models for the study of pathogenesis of SARS-CoV-2 infection Boning Gao UT Southwestern
  • First Name: Ian
    Last Name: Boys
    Affiliation: UT Southwestern
  • First Name: Sara
    Last Name: El Zahed
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Kimberley
    Last Name: Avila
    Affiliation: UT Southwestern
  • First Name: Long Shan
    Last Name: Li
    Affiliation: UT Southwestern
  • First Name: Luc
    Last Name: Girard
    Affiliation: UT Southwestern
  • First Name: Hyunsil
    Last Name: Park
    Affiliation: UT Southwestern
  • First Name: Victor
    Last Name: Stastny
    Affiliation: UT Southwestern
  • First Name: Kenneth
    Last Name: Huffman
    Affiliation: UT Southwestern
  • First Name: Shreoshi Pal
    Last Name: Choudhuri
    Affiliation: UT Southwestern
  • First Name: Kimberly
    Last Name: Batten
    Affiliation: UT Southwestern
  • First Name: Matthew
    Last Name: Esparza
    Affiliation: UT Southwestern
  • First Name: Benjamin
    Last Name: Drapkin
    Affiliation: UT Southwestern
  • First Name: Lisa
    Last Name: Miorin
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: Jerry
    Last Name: Shay
    Affiliation: UT Southwestern
  • First Name: Wendy
    Last Name: Maury
    Affiliation: University of Iowa
  • First Name: Beatriz
    Last Name: Fontoura
    Affiliation: UT Southwestern
  • First Name: John
    Last Name: Schoggins
    Affiliation: UT Southwestern
  • First Name: Adolfo
    Last Name: Garcia-Sastre
    Affiliation: Icahn School of Medicine at Mount Sinai
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:54 Michael Grant michael.grant@yale.edu 2033147088 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Efficacy of afatinib in patients with tumors harboring the uncommon EGFR exon 19 deletion, L747_A750delinsP: a pooled analysis Michael Grant Yale University
  • First Name: Fernando
    Last Name: de Miguel
    Affiliation: Yale University
  • First Name: Michael
    Last Name: Kane
    Affiliation: Yale University
  • First Name: Yong
    Last Name: Kong
    Affiliation: Yale University
  • First Name: Jieling
    Last Name: Miao
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Mary
    Last Name: Redman
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Zenta
    Last Name: Walther
    Affiliation: Yale University
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale University
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Wed, 04/03/2024 - 17:40 Cecil Han ch1182@georgetown.edu 2026878634 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies, Session 6: Cancer Biology The emerging role of deubiquitinating enzyme USP13 in lung cancer plasticity Juntae Kwon Georgetown University School of Medicine Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 12:47 Jessie Hao jessie.hao@emory.edu 4705423594 Session 6: Cancer Biology Co-occurring genomic alterations-guided in silico discovery of therapeutic vulnerability in lung adenocarcinoma Jessie Hao Department of Pharmacology and Chemical Biology, Emory University School of Medicine
  • First Name: Xiulei
    Last Name: Mo
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter